PDT with the construct resulted in significant tumor growth inhibition as well as increased expression of CD70 and CD40 in CD11c+ DCs in tumor-draining lymph nodes and enhanced IFN-y levels in serum, suggesting that the treatment induces an antitumor immune response. This evidence concerns the gene ITGAX and neoplasm.